07:11 AM EDT, 03/10/2025 (MT Newswires) -- BioNTech (BNTX) reported Q4 earnings Monday of 1.08 euros ($1.17) per diluted share, down from 1.88 euros a year earlier.

Comparable analyst estimates were not readily available.

Revenue for the quarter ended Dec. 31 was 1.19 billion euros, down from 1.48 billion euros a year earlier.

Analysts surveyed by FactSet expected 1.09 billion euros.

For 2025, the biotech firm expects revenue of 1.70 billion euros to 2.20 billion euros. Analysts polled by FactSet expect 2.54 billion euros.

Shares of the company were down more than 2.6% in recent premarket activity Monday.

Price: 106.00, Change: -2.78, Percent Change: -2.56